|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Impairment expense | |||||
| Increase/(Decrease) in accounts payable and accrued liabilities | |||||
| Increase/(Decrease) in accounts payable | |||||
| Increase in accrued liabilities | |||||
| (Increase)/Decrease in inventory | |||||
| (Increase) /Decrease in Advances | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from a related party | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the period | |||||
| Cash, cash equivalents and restricted cash at end of the period | |||||
| Supplemental Cash Flow Information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
Loading...